Biological markers of amyloid beta-related mechanisms in Alzheimer's disease - Wikidata - awgldk - TriplyDB

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

http://www.wikidata.org/entity/Q24622136

about

Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic Criteria The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials.Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging The clinical value of large neuroimaging data sets in Alzheimer's disease The Alzheimer's disease neuroimaging initiative: progress report and future plans A Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling.Mismatch negativity (MMN) amplitude as a biomarker of sensory memory deficit in amnestic mild cognitive impairment.Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions Total and phosphorylated tau protein as biological markers of Alzheimer's disease.Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.The future of blood-based biomarkers for Alzheimer's disease.The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Qualification of a surrogate matrix-based absolute quantification method for amyloid-β₄₂ in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification Relationship of dementia screening tests with biomarkers of Alzheimer's disease.A common BACE1 polymorphism is a risk factor for sporadic Creutzfeldt-Jakob disease Dementia screening, biomarkers and protein misfolding: Implications for public health and diagnosis.Identification and quantification of amyloid beta-related peptides in human plasma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.High Throughput ELISAs to Measure a Unique Glycan on Transferrin in Cerebrospinal Fluid: A Possible Extension toward Alzheimer's Disease Biomarker Development Emerging antibody products and Nicotiana manufacturing.Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9.Mass spectral analysis of urine proteomic profiles of dairy cows suffering from clinical ketosis.Magnetization-prepared rapid acquisition with gradient echo magnetic resonance imaging signal and texture features for the prediction of mild cognitive impairment to Alzheimer's disease progression Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease.The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations Alzheimer disease and platelets: how's that relevant.Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytes.Biomarkers of Alzheimer's disease among Mexican Americans.Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study.Neuropathological approaches to cerebral aging and neuroplasticity.Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.A cellular model of amyloid precursor protein processing and amyloid-β peptide production.PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease.

P2860

Q26864063-A54C4642-CD54-416A-9ADC-54E5C8FC99A2 Q27006831-2AEE26E2-58F1-4B53-859E-68753F6F5824 Q27310276-5AB74665-4FCB-460C-B2EA-F4A1FB287724 Q28477836-EFDC5F29-F9EE-4036-9E4A-F14B0A705815 Q28709465-034460A7-134A-4A28-861D-473E54754B39 Q28749585-2875822B-841C-412B-AFF4-89AF27A5AD61 Q30235315-73C85BB2-C0FA-495B-9654-2BA3F6DBB75B Q30446194-A983E574-0CD6-4CF7-AB2E-8835174DF57A Q30845482-ACAB023C-6D8C-4DBB-BA9E-FEE74B65D1B2 Q30971403-44A9C162-9960-4EFE-9497-CA4163B25843 Q30998279-6B40C564-96EA-4AD0-A0AB-8A7A6A5C7677 Q33624674-1ED461B0-1ADF-41D8-922C-BC448BC739A3 Q33842486-BADFDCCB-49E8-400A-A9B5-D2286C409FB5 Q34026317-03A0F2FE-AD56-4DAB-97A7-E5355D547498 Q34065449-F5CBAA48-190D-4724-AF57-17F6480DCCB7 Q34157882-48FAAA39-29F5-4BC6-9CF8-53233B7D111D Q34183016-FC471958-4FCC-4EB5-84AC-563296BD1294 Q34247824-0B7F49E6-0C6B-4D8A-B98B-FD9FD6A60710 Q34405864-22515517-AB2C-475F-A8DC-3669EB76372E Q34570041-9CB484E0-E7DF-4D15-B689-CC8C9834ED20 Q35118876-66D122C4-1A0C-4A9F-B5F0-3106C13E9EE4 Q35178436-7EF539A5-C63D-48C8-B660-E73E6B037E5E Q35194874-1AD01D53-3556-4A85-8FCA-FC6F11D495DD Q35218413-8047C742-7465-40FB-ADD3-D760EC68A388 Q35284971-554DC855-B407-4A0D-8C45-22FD2282FBBE Q35327219-3E9C3B35-27FE-47E7-84EC-A27BEEC07D2B Q35610552-1D15621B-C3DE-470C-AA6D-2E2F1CA1132F Q35641886-3B1ED6EB-DB8D-40BE-A619-CFF42BC6414F Q35775390-992DE8BA-B58F-45B2-8753-5DD7FC3B8F2D Q35991723-82F7C71A-C5BC-4497-8C25-680E8C469BAF Q36165011-661A2B3E-B0ED-4644-914E-8DCDD18A855C Q36535484-03D9C15E-BE30-485B-AEB7-50F310443F1A Q36574825-C2907591-8C17-4961-BC86-8CC19CAA3443 Q36687762-CC0A08FF-68BC-453D-85D7-AEB23DDFAC3F Q36716970-3D9855CD-A947-4ACD-967E-2583D2EC7646 Q36740479-66E781DF-5207-48F4-B7A0-6861480490EA Q36755159-BCAFFB29-E3ED-4E79-A372-640A6B7E6102 Q37410700-D43CFC02-16D1-4FC8-9A30-9058963CAEB4 Q37596735-12F075B7-9052-42B0-9C1D-324B52E8B7A0 Q37718557-076EAF82-B415-456E-87B8-481E5C08461B

P2860

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

http://www.wikidata.org/entity/Q24622136

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

@ast

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

@en

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

@nl

type

label

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

@ast

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

@en

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

@nl

prefLabel

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

@ast

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

@en

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

@nl

P1433

Q24622136-59BEE87B-9916-49B1-98B6-5A1F440D5F07

P1476

Q24622136-C70E4BA4-8DBA-4DEC-AF77-C9FE984D6B09

P2093

Q24622136-0486C3D3-72BE-4ACF-9763-825666738D2F

Q24622136-94034612-98AD-4952-B202-0A0A6479F6A4

Q24622136-CECC8EF1-BA82-43AE-A398-577FD5769BCE

P2860

Q24622136-009F1889-7DBB-446B-B929-1FA41387D6BB

Q24622136-00BF8407-E83E-4397-83E2-E6F057A85E43

Q24622136-0143CB76-3958-4CBD-98C4-F4EBF2985A07

Q24622136-01B53030-24FD-40F0-A002-07C9CF70BCE9

Q24622136-04596094-98C0-4DCB-B50F-FDE8F25C32F6

Q24622136-04AE2FF8-D480-4315-9796-075C8D2761CD

Q24622136-057A8679-F0AD-4F8F-B89A-2C20FFDE75A1

Q24622136-05E60724-18DE-4350-AAF9-56FB7B0F96D8

Q24622136-071ED93C-180D-4DAA-A34C-1380BF9DAEFB

Q24622136-07DD4257-E27B-494C-B7C2-D9B3F97E01C5

P304

Q24622136-C2294B9F-8F32-4340-ADD6-70F088DC9D1A

P31

Q24622136-D5C7AE28-942C-4606-862F-D4FC422D952E

P356

Q24622136-CF3183E1-3C42-43BC-8A26-07AB10AB25DE

P407

Q24622136-40EED9E0-529D-49BC-A214-0FD30EEC60D5

P433

Q24622136-16568E7C-E001-402E-8276-8CE96E17F151

P478

Q24622136-59BCA03F-E11D-40F6-ACCE-127740C921D4

P50

Q24622136-047915E9-3A0D-4D8F-9124-8A4845AF4867

Q24622136-44473EF6-F250-4790-B309-67D4E616EBFF

Q24622136-6B3164BA-9E2E-4AD3-9DC3-6B525CF47A47

Q24622136-95879A06-42C9-42F7-A1C8-6D8A7D363191

Q24622136-F748936D-BA3B-4C3C-A42E-37CC4ACA0921

P577

Q24622136-0D892274-9857-4AB8-A9B0-5F3710B6D5DE

P5875

Q24622136-DCD1A35C-07F5-4758-ACD9-BA48398BA4B6

P698

Q24622136-C6A24E78-E130-4D1D-BDA9-827DD7D6AC04

P921

Q24622136-BABCCE55-B755-46DE-9DC3-5EBD30EE96AB

P932

Q24622136-3B7C84AA-13D0-4CA4-9207-59C4AD9F6DB9

P356

J.EXPNEUROL.2009.09.024

P1433

Experimental Neurology

P1476

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

@en

P2093

Dominic M Walsh

http://www.w3.org/2001/XMLSchema#string

Les M Shaw

http://www.w3.org/2001/XMLSchema#string

Yong Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity

Purification and cloning of amyloid precursor protein beta-secretase from human brain

An Estimate of the Worldwide Prevalence and Direct Costs of Dementia in 2003

Clearance of amyloid-beta by circulating lipoprotein receptors

Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis

Neuropathological stageing of Alzheimer-related changes

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics

P304

334-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EXPNEUROL.2009.09.024

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

223

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Zetterberg

John Q. Trojanowski

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26881004

http://www.w3.org/2001/XMLSchema#string

P698

19815015

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2896007

http://www.w3.org/2001/XMLSchema#string